Irina V. Gribkova

Prof. Irina V. Gribkova

State Budgetary Institution «Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department», Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2016 in Scientific Reports
Verified
Journal Article
Open access
IGIrina V. Gribkova
Irina V. Gribkova
ELElena N. Lipets
Elena N. Lipets
IRIrina G. Rekhtina
Irina G. Rekhtina
ABAlex I. Bernakevich
Alex I. Bernakevich
DADorzho B. Ayusheev
Dorzho B. Ayusheev
ESElena Sinauridze
Elena Sinauridze
A new oral anticoagulant, dabigatran etexilate (DE, a prodrug of direct thrombin inhibitor (DTI) dabigatran), has been used clinically to prevent thrombosis. The assessment of dabigatran efficiency is necessary in some clinical cases, such as renal insufficiency, risk of bleeding, and drug interactions. However, a specific thrombin generation test (TGT) that is one of the most informative and sensitive to anticoagulant therapy (calibrated automated thrombinography (САТ)) shows a paradoxical increase of test parameters, such as endogenous thrombin potential (ETP) and peak thrombin, in patients receiving DE. The paradoxical behaviour of ETP and peak thrombin in these patients in the presence of DTIs is mostly caused by a decrease in the activity of thrombin in the α2-macroglobulin-thrombin complex that is used as a calibrator in CAT. For a correct estimation of the TGT parameters in patient’s plasma containing DTIs we proposed to use our previously described alternative calibration method that is based on the measurement of the fluorescence signal of a well-known concentration of the reaction product (7-amino-4-methylcoumarin). In this study, the validity of such approach was demonstrated in an ex vivo study in patients with knee replacement and two special patients with multiple myeloma, who received DE for thrombosis prophylaxis.

9 March 2014 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
ESElena A. Seregina
Elena A. Seregina
ONOlga F. Nikulina
Olga F. Nikulina
NTNina V. Tsvetaeva
Nina V. Tsvetaeva
MRMaya N. Rodionova
Maya N. Rodionova
IGIrina V. Gribkova
Irina V. Gribkova
FAFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov

Verified
Journal Article
Open access
PDF file
HGHristo Gagov
Hristo Gagov
IGIrina V. Gribkova
Irina V. Gribkova
VSVladimir N. Serebryakov
Vladimir N. Serebryakov
RSRudolf Schubert
Rudolf Schubert
Nitric oxide (NO) is a powerful vasodilator in different vascular beds and NO-donors are widely used in clinical practice. Early data suggested that NO and NO-donors activate vascular smooth muscle high-conductance, calcium-activated potassium channels (BK channels). There exist two hypotheses explaining the effect of NO and NO-donors on BK channels—one stating that protein kinase G (PKG) mediates the effect of NO, and the other one stating that NO acts directly on the channel. Thus, the degree of contribution of PKG to the NO-induced activation of the BK channel is still not completely clear. This study tested the hypothesis that the sodium nitroprusside (SNP)-induced activation of vascular smooth muscle BK channels is fully mediated by PKG. This hypothesis was investigated using the patch-clamp technique and freshly isolated smooth muscle cells from rat tail artery. In whole-cell experiments, SNP considerably increased the outward current compared with the addition of the bath solution. SNP did not alter the current in the presence of iberiotoxin, the specific blocker of BK channels, during co-application with hydroxocobalamin, an NO-scavenger, and in the presence of Rp-8-Br-PET-cGMPS, the specific PKG-inhibitor. In inside-out patches, the activity of BK channels was increased by SNP, SNAP, and DEA-NO. However, these effects did not differ from the effect of the application of drug-free bath solution. Furthermore, a similar increase in single BK channel activity was induced by Rp-8-Br-PET-cGMPS, Rp-8-Br-PET-cGMPS together with SNP, hydroxocobalamin, and hydroxocobalamin together with SNP or DEA-NO. Finally, the activity of excised BK channels did not change in the absence of any application but was considerably increased by PKG compared with the addition of drug-free bath solution. These results suggest that NO released from NO-donors stimulates the BK current only through activation of PKG.

1 January 2014 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
IGIrina V. Gribkova
Irina V. Gribkova
VSVera A. Spiridonova
Vera A. Spiridonova
AGAlexander S. Gorbatenko
Alexander S. Gorbatenko
SDStepan S. Denisov
Stepan S. Denisov
FAFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov
ESElena Sinauridze
Elena Sinauridze
Investigation of inhibitory effect of two single-stranded DNA thrombin-inhibiting aptamers (15TBA and 31TBA) on fibrin polymerization in fibrinogen solutions and comparison of anticoagulant properties of these aptamers by a new global coagulation test of thrombodynamics. Measurement of aptamers’ functional stability in human plasma and blood in vitro in order to investigate the involvement of 3’-exonuclease in fast decrease of aptamers’ functional activity in vivo. Thrombin inhibition activity was measured in a buffer system in vitro as effects of aptamers on fibrin polymerization. Anticoagulant activity was investigated by measuring the spatial clot growth rate in the presence of aptamers. The stability of aptamers during incubation in human plasma was investigated in vitro by measuring activated partial thromboplastin time. Both aptamers dose-dependently inhibit fibrin polymerization in a buffer solution (IC50=10 nm for 15TBA and 3 nm for 31TBA) and are effective anticoagulants in human plasma (IC50 for spatial clot growth rate decreasing are 9.5 μmol/l and 4.0 μmol/l for 15TBA and 31TBA, correspondingly). Both aptamers remain stable in plasma or whole blood in vitro for at least 4 h. It was shown that 31TBA was 2–3 times more effective than 15TBA. Both aptamers were stable in human plasma and whole blood in vitro. So, the 3’-exonuclease could not be the reason for fast decrease of aptamers’ functional activity in vivo. The main role in the removal of oligonucleotides from the circulation is played obviously by the liver.

27 January 2020 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
IGIrina V. Gribkova
Irina V. Gribkova
GGGennady M. Galstyan
Gennady M. Galstyan
TPTatyana Y. Polyanskaya
Tatyana Y. Polyanskaya
ESElena I. Sinauridze
Elena I. Sinauridze
Thrombin generation test (TGT) is well established tool to research blood coagulation in plasma of hemophilia patients. Traditionally coagulation in this test is triggered by a tissue factor (TF), an extrinsic coagulation pathway activator. However, it is known that disorders of the intrinsic pathway are most important for coagulation in hemophilia. In this study, we hypothesized that triggering coagulation via the intrinsic pathway could increase a sensitivity of the TGT to monitor hemophilia treatment. The aim of this study was to compare thrombin generation in hemophilia A patients with inhibitors to factor VIII before and after infusion of bypassing agent [recombinant-activated factor VIIa (rVIIa)] using standard activation of coagulation by TF or by kaolin, an activator of coagulation by intrinsic pathway. Endogenous thrombin potential (ETP) in nine patients was measured. ETP before (ETP 0 ) and 60 min after rVIIa infusion (ETP 60 ) were compared. It was shown that ETP 0 and ETP 60 were significantly different when using any coagulation activator (paired Student's t test, P = 0.017 and 3.7 × 10 −5 for clotting activation by TF and kaolin, respectively). The ratios of ETP 60 /ETP 0 were 1.2 ± 0.2 or 30.0 ± 22.4 (mean ± SD, n = 9) for coagulation activated by TF or kaolin, respectively, and were significantly different (paired Student's t test, P < 0.005). The TGT clearly distinguished between ETP 0 and ETP 60 in the case of any coagulation activator, but ETP increasing after rVIIa infusion was significantly higher when activated with kaolin. This provided increased sensitivity of this method for monitoring hemophilia therapy.

1 September 2018 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
IGIrina V. Gribkova
Irina V. Gribkova
KKKoroleva N.S. Koroleva
Koroleva N.S. Koroleva
DDDavydovskaya M.V. Davydovskaya
Davydovskaya M.V. Davydovskaya
MMMurashko A.V. Murashko
Murashko A.V. Murashko
3R3 N.I. Pirogov Russian National Research Medical University of Minzdrav of Russia
3 N.I. Pirogov Russian National Research Medical University of Minzdrav of Russia